GIP showed a diminished effect in boosting insulin secretion in T2D patients, for reasons that are still not understood
About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features Accessibility 2026 Google LLC
In preclinical studies, cotadutide demonstrated a more pronounced loss of body weight, reduction in food intake, and superior improvement in glycemic parameters in rodents compared to a GLP-1 RA
Other medical histories may require individualized risk assessment
Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG
Associate research fellow Benjamin Bonenti, who is part of the UQ team that researches the harm of some peptides, said the testing revealed a "big problem"